Skip to main content
. 2024 Mar 14;15:1342647. doi: 10.3389/fimmu.2024.1342647

Figure 1.

Figure 1

STING downstream genes are correlated with the clinical outcomes and traits of cervical cancer. The curves illustrate the overall survival of cervical cancer patients stratified based on the expression status of three downstream genes of STING, namely CCL5 (A), CXCL9 (B), and CXCL10 (C) based on the TCGA dataset. The curves present the relapse free survival of patients with cervical cancer grouped by the expression level of three downstream genes of STING, namely CCL5 (D), CXCL9 (E), and CXCL10 (F) according to TCGA dataset. The diagram depicts the clinical stages of different expression levels of CCL5 (G), CXCL9 (H), and CXCL10 (I) based on TCGA dataset. The diagram depicts the clinical metastatic status of different expression levels of CCL5 (J), CXCL9 (K), and CXCL10 (L) based on TCGA dataset. The expression level of CCL5 (M), CXCL9 (N), and CXCL10 (O) in different histological types based on TCGA dataset. The expression level of CCL5 (P), CXCL9 (Q), and CXCL10 (R) in different histological types according to the GSE192897 dataset. * in this figure represents P < 0.05, ** represents P < 0.01, *** indicates P < 0.001, and **** represents P < 0.0001.